Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

AMBA vs CAMP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AMBA Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 7–3 Matrix Metrics)

AMBA Overall Winner 6-Pillar Tally: AMBA 5 – 1 CAMP Matrix Metrics: AMBA 7 – 3 CAMP

As of Nov 17, 2026, Ambarella, Inc. (AMBA) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMBA carries a Unified Composite Score of 47.3/100 (HOLD) at $54.00 (82.1x Forward P/E, -14.9% operating margin), whereas CAMP carries 43.9/100 (HOLD) at $4.00 (N/M Forward P/E, -991.8% operating margin).

  • Growth vs. Quality Trade-Off: AMBA earns the overall head-to-head edge with a stronger Unified Composite Score (47.3/100 HOLD vs. CAMP 43.9/100 HOLD) and 2.60β · 64% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: AMBA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.6); meanwhile CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AMBA vs CAMP
AMBA NASDAQ Head-to-Head Winner
Ambarella, Inc. Ordinary Shares
Semiconductors & Related Devices
$54.00
-1.87% 1D
Market Cap $2.7B
TTM Revenue $418M
Forward P/E 82.1x
Beta / 30D Vol 2.60β · 64% Vol
Unified Composite Score
47.3 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 73.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -6.2%), weak momentum, RSI 35
RSI-14: 34.6 · SMA20: $61.81 · SMA50: $64.61
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap $238.5M
TTM Revenue $5.3M
Forward P/E N/M
Beta / 30D Vol 1.35β · 94% Vol
Unified Composite Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.9 · SMA20: $3.82 · SMA50: $3.84

6-Pillar Scorecard Institutional Category Breakdown (AMBA 5 – 1 CAMP)

Columns: Metric · AMBA · CAMP
1. Valuation Multiples AMBA
Forward P/E 82.1x N/M
Trailing P/E 57.1x N/M
PEG Ratio 4.97x N/M
EV / Revenue 6.1x 26.6x
2. Growth & Scale AMBA
Revenue Growth (YoY) +13.2% +138.9%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $418M $5.3M
Market Cap $2.7B $238.5M
3. Profitability & Quality AMBA
Gross Margin 58.5% N/A
Operating Margin -14.9% -991.8%
Net Profit Margin -13.5% 0.0%
Return on Equity (ROE) -9.4% -146.1%
4. Balance Sheet & Cash Flow AMBA
Cash Generation (TTM) $9.7M -$26M
Cash Flow Margin 2.3% N/A
Net Cash / Leverage $89M Net Cash $97M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CAMP
Options Structure Phase BREAKDOWN UNCLASSIFIED
Current IV / %ile 92.4% (16th %ile) N/A (N/A)
Put/Call OI Skew 1.25x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat AMBA
OpEx & R&D Intensity 73.4% of Rev ($307M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Semiconductor Equipment & Materials Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AMBA (7) vs CAMP (3)
Institutional Metric AMBA CAMP Criterion Row Edge
Market Capitalization
Scale
$2.7B $238.5M Larger Scale AMBA
Trailing P/E Ratio
Valuation
57.1x N/M Lower Multiple AMBA
Forward P/E Ratio
Valuation
82.1x N/M Lower Multiple AMBA
Revenue Growth (YoY)
Growth
+13.2% +138.9% Higher Growth CAMP
Operating Margin (TTM)
Profitability
-14.9% -991.8% Higher Margin AMBA
Net Profit Margin
Profitability
-13.5% 0.0% Higher Margin CAMP
Return on Equity (ROE)
Capital Efficiency
-9.4% -146.1% Higher ROE AMBA
52-Week Range Position
Momentum
12% ($48–$96) 23% ($3–$8) Stronger Trend CAMP
Beta / 30D Volatility
Risk Regime
2.60β · 64% Vol 1.35β · 94% Vol Lower Realized Risk AMBA
Unified Institutional Score
Composite Signal
47.3 / 100 (HOLD) 43.9 / 100 (HOLD) Higher Composite AMBA
Trailing 12M Revenue (USD)
Operating Scale
$418M $5.3M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
58.5% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
4.97x PEG · 6.1x EV/Rev N/M PEG · 26.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$9.7M ($89M Net Cash) -$26M ($97M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CAMP +41.35 pp
AMBA: -13.96% · CAMP: +27.39%
3M Horizon CAMP +13.62 pp
AMBA: -27.6% · CAMP: -13.98%
6M Horizon CAMP +25.98 pp
AMBA: -29.59% · CAMP: -3.61%
1Y Horizon CAMP +36.08 pp
AMBA: -38.52% · CAMP: -2.44%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period AMBA Revenue CAMP Revenue AMBA Op. Margin CAMP Op. Margin Margin Leader
FY2019 $230M N/A -17.7% N/A AMBA
FY2020 $230M N/A -21.7% N/A AMBA
FY2021 $220M N/A -27.4% N/A AMBA
FY2022 $330M N/A -8.9% N/A AMBA
FY2023 $340M $0M -22.0% -14822.6% AMBA
FY2024 $230M $0M -68.2% -8142.3% AMBA
FY2025 $280M $0M -44.4% -1502.4% AMBA
FY2026 $390M N/A -21.1% N/A AMBA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AMBA BREAKDOWN
122d in phase · OBV DISTRIBUTION
Current IV 92.4%
IV Percentile 16th %ile
Put/Call OI Skew 1.25x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact AMBA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CAMP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CAMP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $55.03 · IV 90.5%

AMBA Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($5,503)

Compare $5,503 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 90.5% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $60 / $67.5 Bull Call Spread

Buy 1x $60C · Sell 1x $67.5C · 32d

Net Entry $63 Debit
T+5d @ +5% Move +$42 (+66%)
Max Risk / Buffer $63 Capped
5d Edge & Liquidity 2.0x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Dec 18 $50 / $45 Bull Put Spread

Sell 1x $50P · Buy 1x $45P · 32d

Net Entry $80 Credit
Max Credit / Yield +$80 (+19.0% RoM)
Max Risk / Buffer -10.6% Cushion ($420 Mgn)
5d Edge & Liquidity 72% PoP · Liq C
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $60 / $50 Bear Put Spread

Buy 1x $60P · Sell 1x $50P · 32d

Net Entry $580 Debit
T+5d @ -5% Drop +$85 (+15%)
Max Risk / Buffer $580 Capped
5d Edge & Liquidity 0.7x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AMBA Moat Profile Cyclical / Execution-Driven Positioning
Semiconductor Equipment & Materials Operator
Competes within the Semiconductor Equipment & Materials value chain with $2.7B market capitalization and -14.9% operating margin.
OpEx & R&D Reinvestment 73.4% of Rev ($307M)
90D Engineering Disclosures 0 Published
Mapped Supply-Chain Ecosystem (16 partners):
Taiwan Semiconductor Manufacturing Company ASE Technology Holding Amkor Technology Synopsys
CAMP Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $238.5M market capitalization and -991.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ AMBA vs CAMP Key Questions & Quantitative Answers

As of Nov 17, 2026, Ambarella, Inc. (AMBA) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AMBA carries a Unified Composite Score of 47.3/100 (HOLD) at $54.00 (82.1x Forward P/E, -14.9% operating margin), whereas CAMP carries 43.9/100 (HOLD) at $4.00 (N/M Forward P/E, -991.8% operating margin). Growth vs. Quality Trade-Off: AMBA earns the overall head-to-head edge with a stronger Unified Composite Score (47.3/100 HOLD vs. CAMP 43.9/100 HOLD) and 2.60β · 64% Vol risk profile, whereas CAMP leads top-line expansion (+138.9% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: AMBA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.6); meanwhile CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AMBA leads the Growth & Scale pillar: AMBA posts +13.2% YoY revenue growth and +0.0% YoY earnings growth on $418M TTM revenue (58.5% gross margin, -14.9% operating margin), compared with CAMP at +138.9% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (N/A gross margin, -991.8% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), AMBA cumulative revenue shifted +69.6% while CAMP shifted N/A. In operating R&D and SG&A reinvestment, AMBA deploys 73.4% of Rev ($307M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CAMP.

AMBA screens cheaper on headline valuation multiples. AMBA trades at 82.1x Forward P/E, 57.1x Trailing P/E, 4.97x PEG, and 6.1x EV/Revenue (2.3% FCF margin), whereas CAMP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 26.6x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AMBA (-9.4% ROE) versus CAMP (-146.1% ROE) capital efficiency.

In options market volatility and institutional positioning, AMBA carries 92.4% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.25x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.60β · 64% Vol realized risk). By comparison, CAMP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.35β · 94% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.